Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

609 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution.
Maiz C, Silva F, Domínguez F, Galindo H, Camus M, León A, Oddó D, Villarroel A, Razmilic D, Navarro ME, Medina L, Merino T, Vines E, Peña J, Maldonado D, Pinto MP, Acevedo F, Sánchez C. Maiz C, et al. Among authors: dominguez f. Ecancermedicalscience. 2020 Jan 23;14:1005. doi: 10.3332/ecancer.2020.1005. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32104207 Free PMC article.
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data.
Walbaum B, Acevedo F, Medina L, Bravo ML, Merino T, Camus M, Dominguez F, Mondaca S, Galindo H, Nervi B, Ibañez C, Madrid J, Muñiz S, Peña J, Koch É, Garrido M, Pinto MP, Sánchez C. Walbaum B, et al. Among authors: dominguez f. Ecancermedicalscience. 2021 Feb 1;15:1178. doi: 10.3332/ecancer.2021.1178. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33777171 Free PMC article.
Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer.
Canteros D, Walbaum B, Córdova-Delgado M, Torrealba A, Reyes C, Navarro ME, Razmilic D, Camus M, Dominguez F, Navarrete O, Pinto MP, Pizarro G, Acevedo F, Sánchez C. Canteros D, et al. Among authors: dominguez f. Ecancermedicalscience. 2022 May 23;16:1396. doi: 10.3332/ecancer.2022.1396. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35919242 Free PMC article.
The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer.
Rivas M, Acevedo F, Dominguez F, Galindo H, Camus M, Oddo D, Villarroel A, Razmilic D, Peña J, Munoz Medel M, Navarro ME, Perez-Sepulveda A, Medina L, Merino T, Briones J, Kalergis A, Sanchez C. Rivas M, et al. Among authors: dominguez f. Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2209-2212. doi: 10.31557/APJCP.2019.20.7.2209. Asian Pac J Cancer Prev. 2019. PMID: 31350986 Free PMC article.
First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution.
Walbaum B, Acevedo F, Medina L, Bravo ML, Merino T, Camus M, Dominguez F, Mondaca S, Galindo H, Nervi B, Ibañez C, Madrid J, Peña J, Koch E, Garrido M, Pinto MP, Sánchez C. Walbaum B, et al. Among authors: dominguez f. Curr Med Res Opin. 2020 Jul;36(7):1195-1199. doi: 10.1080/03007995.2020.1763282. Epub 2020 May 14. Curr Med Res Opin. 2020. PMID: 32351137
Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
Walbaum B, Puschel K, Medina L, Merino T, Camus M, Razmilic D, Navarro ME, Dominguez F, Cordova-Delgado M, Pinto MP, Acevedo F, Sánchez C. Walbaum B, et al. Among authors: dominguez f. Breast Cancer Res Treat. 2021 Sep;189(2):561-569. doi: 10.1007/s10549-021-06317-1. Epub 2021 Jul 10. Breast Cancer Res Treat. 2021. PMID: 34244869
609 results